Navigation Links
Study helps explain how pathogenic E. coli bacterium causes illness
Date:3/14/2011

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown how the O157:H7 strain of Escherichia coli causes infection and thrives by manipulating the host immune response. The bacterium secretes a protein called NleH1 that directs the host immune enzyme IKK-beta to alter specific immune responses. This process not only helps the bacterium evade elimination by the immune system, it also works to prolong the survival of the infected host, enabling the bacterium to persist and ultimately spread to unaffected individuals. This finely balanced mechanism, observed in both laboratory and animal models, could be relevant to other pathogens involved in foodborne diseases.

While most E. coli strains help check the growth of harmful bacteria in the guts of animals and humans, a few E. coli strains, such as O157:H7, can cause severe diarrhea, abdominal cramps and, in rare cases, death. Human cases of E. coli O157:H7 have been linked to consumption of raw, undercooked, or spoiled meat.

NIAID researchers plan to use the new information to further study how the host immune system mounts a response to E. coli O157:H7 when infection begins and how the bacterium selectively blocks these defenses. Several foodborne pathogens, including Shigella and Salmonella, use a similar secretion system to disrupt host immune responses and infect gut cells.


'/>"/>

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1

Related medicine news :

1. Study seeks to halt progression of diabetic nephropathy
2. Neuro signals study gives new insight into brain disorders
3. Text Messages May Help Smokers Kick the Addiction, Small Study Finds
4. Adults With HIV at Increased Risk of Bone Fractures, Study Finds
5. New study shows government spending preferences of Americans
6. Wayne State study links testosterone with mens ability to woo potential mates
7. Depression Seems to Increase Risk of Kidney Failure: Study
8. UTHealth study: Stem cells may provide treatment for brain injuries
9. Humans Age at Same Pace as Other Primates, Study Finds
10. Poor Diet in Pregnancy Tied to Disease in Offspring: Rat Study
11. Animal Study May Explain Low Birth Weight-Obesity Link
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Reltok Nasal Products proudly announces that Boston Medical Products, ... nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product ... a newly patented safety device secured by nasal surgeons onto the floor of the ...
(Date:4/29/2016)... ... 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 out ... earning them second place for Tampa’s Best Places to Work. They were ranked in ... a great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. “We ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... promote their animal line of probiotics, Petbiotics ™, as they fondly call ... of animal rescue groups networking for their non-profit organizations. Animal rescues across the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intellitec Solutions is pleased to ... Dynamics GP for one their long-term care clients. Working together with the clients ... key clinical management systems, and delivered a fully integrated accounting and business-management solution ...
(Date:4/29/2016)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... saying it is time to set the record straight. Traditionally, BC and AD has ... possibly be true and offers explanation. , “To start with, the Name of the ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
(Date:4/27/2016)... Avril 2016   ... +5% sur le trimestre, soutenu par une croissance ... Croissance de +16% des ventes aux hôpitaux ... Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur ... aujourd,hui son chiffre d,affaires pour le premier trimestre ...
Breaking Medicine Technology: